CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Efficacy and safety of subcutaneous guselkumab induction therapy in patients with ulcerative colitis: results through week 24 from the phase 3 ASTRO study
DOI 10.1055/s-0045-1810725
Bibliografische Angaben
Nachweis in CareLit
Autor:innenU Seidler, M Long, J R Allegretti, S Danese, M Germinaro, T Baker, Y Alvarez, S Jorgens, L Jiang, H Zhang, T Hisamatsu, D T Rubin, L Peyrin-Biroulet
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2025
Jahrgang / SeitenJg. 63 · S. e417-e418
Kernaussage aus der Literatur
Abstract-Vorschau
Efficacy and safety of subcutaneous guselkumab induction therapy in patients with ulcerative colitis: results through week 24 from the phase 3 ASTRO study
Zitieren
Zitierempfehlung
U Seidler, M Long, J R Allegretti, S Danese, M Germinaro, T Baker, Y Alvarez, S Jorgens, L Jiang, H Zhang, T Hisamatsu, D T Rubin, L Peyrin-Biroulet (2025) Efficacy and safety of subcutaneous guselkumab induction therapy in patients with ulcerative colitis: results through week 24 from the phase 3 ASTRO study. Zeitschrift für Gastroenterologie, 63 (08), e417-e418. https://doi.org/10.1055/s-0045-1810725
Mit CareLit weiterarbeiten